Sai Life Sciences Limited
NSE: SAILIFEINE570L01029·HealthcareSmallcap 250·www.sailife.com ↗·Mcap ₹34,198 Cr·Listed 2024
₹1,592.20▼ ₹2.70  (−0.17%)
52W: ₹784 – ₹1,697 · Vol: 2.7L shares · Close 25 Sept
Set Alert

Quarterly results

consolidated · as filed with NSE · Q1 FY27 back to Q3 FY25
₹ croreQ1 FY27Q4 FY26Q3 FY26Q2 FY26Q1 FY26Q4 FY25Q3 FY25
Revenue from operations554602556537496580440
Other income3.515.58.415.39.99.69.1
Total expenses460479422441426470377
EBITDA148177188146121158120
EBITDA margin26.7%29.3%33.8%27.1%24.4%27.2%27.2%
Finance costs7.67.89.79.412.410.923.1
Depreciation45.945.344.139.737.737.534.1
Profit before tax9813913411280.711971.6
Tax24.73533.828.220.330.517.8
Net profit73.310410083.860.588.353.9
Net margin13.2%17.3%18.0%15.6%12.2%15.2%12.2%
EPS (₹)3.464.934.774.012.904.242.89
Net profit YoY+21.2%+18.1%+86.4%––––

Annual results

financial years ending March · from the fourth-quarter filings
₹ croreFY26FY25
Revenue from operations2,1921,695
Other income49.136.8
Total expenses1,7671,504
EBITDA631406
EBITDA margin28.8%23.9%
Finance costs39.276.2
Depreciation167139
Profit before tax466228
Tax11757.6
Net profit349170
Net margin15.9%10.0%
EPS (₹)16.638.83
Net profit YoY+105.1%–
EPS is as filed for each period and is not restated for later bonus issues or splits.

Cash flow

annual · ₹ crore
₹ croreFY26FY25
Operating cash flow509314
Investing cash flow−395−537
Financing cash flow−124301
Capital expenditure593369
Free cash flow (CFO − capex)−83.8−55.2

Net profit trend

annual, ₹ crore
FY25
₹170
FY26
₹349+105%

Result filings

as filed with NSE · PDF and XBRL
PeriodBasisFiledDocuments
Q1 FY27Consolidated6 Aug 2026 PDF XBRL
Q1 FY27Standalone6 Aug 2026 PDF XBRL
Q4 FY26Consolidated14 May 2026PDF on NSE XBRL
Q4 FY26Standalone14 May 2026PDF on NSE XBRL
Q3 FY26Consolidated5 Feb 2026PDF on NSE XBRL
Q3 FY26Standalone5 Feb 2026PDF on NSE XBRL
Q2 FY26Consolidated6 Nov 2025PDF on NSE XBRL
Q2 FY26Standalone6 Nov 2025PDF on NSE XBRL
Q1 FY26Consolidated7 Aug 2025PDF on NSE XBRL
Q1 FY26Standalone7 Aug 2025PDF on NSE XBRL

Annual reports

NSE archive
Key ratios
P/E (TTM)5Y avg 76.9×93.2×
P/B5Y avg 7.96×13.58×
ROEFY26, on average equity15.1%
Net margin15.9%
Debt / equity0.04×
Revenue CAGR (3Y)–
Profit CAGR (3Y)–
EPS (TTM)₹17.08
Market cap₹33,720 Cr
Computed from the filings and the last close. Market cap uses the latest share count from the balance sheet.
P/B vs history
13.58×
vs 3-point avg 7.96× (+70%)
7.57× low7.96× avg13.58× high
History points are balance-sheet dates (2025 → 2026), priced at the adjusted close on each date.
Balance sheet 31 Mar 2026
Total assets₹3,626 Cr+15%
Net worth₹2,484 Cr+17%
Total borrowings₹95 Cr−26%
Cash & bank balances₹82 Cr−10%
Investments₹51 Cr+2499%
Inventories₹151 Cr+27%
Trade receivables₹374 Cr+5%
Trade payables₹285 Cr−12%
Change vs the same date a year earlier.
Shareholding 30 Jun 2026
%Jun 26Mar 26Dec 25Sept 25Jun 25Mar 25Dec 24Dec 24
Promoter34.5334.6134.7034.9435.1535.1735.2435.24
FII19.6521.1721.4022.5014.5812.3611.727.64
DII32.7131.5431.4129.9121.6413.2611.955.61
of which MF29.4727.8027.5726.1718.73–––
Retail6.786.125.947.916.567.698.8718.67
Other public6.336.566.554.7422.0731.5232.2232.84
1,25,096 shareholders · NSE shareholding pattern filings.